The Celotex Asbestos Trust Has Operated Since 1998. Construction Trades Workers File the Majority of Claims. The Distribution Procedures Explained.

The Celotex Asbestos Settlement Trust has operated since 1998. It handles personal injury claims arising from asbestos-containing products manufactured by Celotex Corporation and its subsidiary Carey Canada, Inc. Celotex Corporation filed for Chapter 11 bankruptcy in the Middle District of Florida in 1990 (Case No. 8:90-bk-10016). The trust was established as part of the Chapter 11 reorganization plan under Section 524(g) of the Bankruptcy Code, the provision Congress added in 1994 specifically to authorize asbestos personal injury trusts.

For people with mesothelioma whose exposure can be traced to Celotex products, the trust is one of the most-cited filing destinations in the construction trades exposure pattern. Celotex’s product line was broad, the company’s reach in commercial and industrial construction was substantial, and the worksite penetration of its roofing, insulation, fire protection, and acoustical materials lasted through the 1970s.

This is the trust profile.

Why Celotex Matters in the Trust Landscape

The 524(g) trust system was created by Congress in 1994 to handle the wave of asbestos personal injury claims that overwhelmed the bankruptcy system in the 1980s and early 1990s. Section 524(g) of the Bankruptcy Code allows a debtor company to channel all current and future asbestos claims to a trust funded by the company’s reorganization assets. The trust handles the claims; the reorganized company emerges from bankruptcy without ongoing asbestos liability.

Celotex was one of the major industrial product manufacturers caught in that wave. The company’s bankruptcy filing in 1990 came at the peak of asbestos litigation activity. The trust that emerged in 1998 was structured to handle claims for as long as the disease cohort exposed to Celotex products continued to be diagnosed.

Mesothelioma has a 20 to 50 year latency period between exposure and diagnosis. Workers exposed to Celotex products in the 1960s and 1970s, the decade of heaviest asbestos use, are still being diagnosed in the 2020s. The trust’s claim flow has continued for more than two decades.

The broader trust system handles a substantial portion of all asbestos compensation today. KCIC and other industry trackers consistently report that trust claims now represent a larger share of asbestos compensation than civil verdicts, simply because the major historical defendants are now in trusts rather than civil court. See the asbestos trust fund compensation overview for the broader system, and the 2026 trust fund payouts coverage for recent payout patterns.

What Celotex Made

Celotex Corporation’s product portfolio spanned several construction product categories. The company made roofing materials including built-up roofing systems with asbestos felt. It made acoustical and ceiling materials including sprayed acoustical surfaces. It made fire protection products including spray-applied fireproofing for structural steel. It made insulation products for commercial and industrial applications.

Carey Canada, the Celotex subsidiary, was a Quebec asbestos mining and product manufacturer. Carey Canada products are covered under the same trust as Celotex products. The Carey Canada history adds an additional exposure layer: Carey Canada workers in Quebec mining operations and US workers handling Carey Canada products both have potential trust claims.

The product mix matters for understanding the claim demographics. Roofing, insulation, fire protection, and acoustical materials are installed primarily in commercial and industrial construction. The workers who handled these products were construction trades workers: insulators applying spray fireproofing on structural steel, roofers installing built-up roofing systems, sheet metal workers cutting and fitting acoustical panels, drywallers and finishers working on ceiling systems, plasterers spraying acoustical finishes.

These were union and non-union construction trades. The exposure was concentrated during installation and during demolition or renovation when the products were disturbed. See the construction workers asbestos exposure profile, the boilermakers asbestos profile, and the plumbers and pipefitters profile for the broader trades-by-trades exposure patterns.

How the 8-Tier Disease Structure Works

The Celotex TDP organizes claims into eight disease levels. The structure is a common pattern in 524(g) trust documents: lower-numbered levels for less severe asbestos-related conditions, higher-numbered levels for the most severe.

Level I is generally non-malignant pleural disease. Level II covers asbestosis with lower-grade impairment. Higher levels address more severe asbestosis, asbestos-related lung cancers, and the highest tier is reserved for mesothelioma. Each tier has specific medical and exposure criteria in the TDP. Mesothelioma diagnosis requires histopathology confirmation and supporting clinical documentation. Asbestos-related lung cancer requires medical evidence of asbestos exposure plus the lung cancer diagnosis. Asbestosis requires radiographic evidence and pulmonary function testing meeting specific criteria.

Each disease level has a published scheduled value. The scheduled value is what the trust would pay at 100% payment percentage. The actual payment to a claimant is the scheduled value multiplied by the trust’s current payment percentage. If the scheduled value for a Level VIII mesothelioma claim is $X and the trust’s current payment percentage is 17%, the claimant receives $X multiplied by 0.17.

The payment percentage is set based on the trust’s actuarial position: how many claims are projected over the trust’s lifetime, how much in assets remains, and what reserves are needed for future claimants. KCIC and trust administrator filings track payment percentage changes across the major trusts. Across the active 524(g) system, payment percentages typically range from 1% to 25%.

What Goes Into a Trust Claim

Filing a Celotex trust claim requires three categories of documentation: medical evidence of disease, exposure history showing contact with Celotex or Carey Canada products, and supporting documentation per the TDP requirements.

Medical evidence for a mesothelioma claim typically includes the pathology report confirming mesothelioma diagnosis, treating physician records, and imaging studies. The TDP specifies the documentation requirements for each disease level. Mesothelioma claims have the most stringent diagnostic requirements because of the disease’s severity and the corresponding scheduled value.

Exposure history is the document that connects the claimant to the trust’s covered products. For Celotex, the exposure history needs to identify which Celotex or Carey Canada products were present at the claimant’s worksite, when, and through what work activities the claimant was exposed. A construction worker who installed Celotex roofing on commercial buildings in the 1960s and 1970s, for example, would document the worksites, the time period, the products handled, and the work activities (cutting felt, installing built-up systems, removing old roofing for replacement).

Supporting documentation can include union work records, employment records, social security earnings records showing employer history, military service records for veterans, and witness statements from co-workers. The strength of the exposure history affects whether a claim qualifies for expedited review or individual review under the TDP.

Most claims are handled through expedited review when the documentation clearly meets the TDP criteria for a specific disease level. Individual review is available for claims that don’t fit the expedited criteria but for which the claimant believes the trust should pay an individualized amount.

The Broader Trust System Context

The Celotex trust is one of more than 60 active asbestos 524(g) trusts. The Government Accountability Office’s 2011 report on asbestos trust administration documented the system at that point. RAND Corporation has published periodic resource estimates and projections for the active trusts. RAND’s most recent estimate places approximately $30 billion in remaining assets across the active trust system as of 2024-2026.

For people with mesothelioma, the multi-trust filing pattern is typical. A worker in the construction trades during the 1960s and 1970s was exposed to products from many manufacturers across many worksites. The exposure history typically supports claims with multiple trusts: Celotex for roofing, insulation, fire protection, or acoustical product exposure; Combustion Engineering for industrial boiler insulation exposure; Babcock and Wilcox for boiler exposure in power generation or naval applications; Armstrong World Industries for ceiling tile and floor tile exposure; Owens Corning for pipe and equipment insulation; US Gypsum for drywall joint compound exposure; and others depending on the specific exposure pattern.

An attorney who handles mesothelioma cases can identify which trusts apply to a specific exposure history. The exposure history document is the central piece. Once it’s developed, the attorney files claims with each applicable trust, and the trust claims proceed in parallel with any civil litigation against solvent defendants.

Filing Deadlines and Statute of Limitations

Trust claim deadlines generally follow the statute of limitations of the state where the claimant lives or where the exposure occurred. For mesothelioma, most state statutes of limitations run from the date of diagnosis under the discovery rule, not the date of exposure. The exact deadline varies by state.

Filing earlier than the deadline is strongly preferred for two reasons. First, trust claim review takes time. Filing close to a deadline risks the claim being deemed untimely if the trust’s review process surfaces additional documentation requirements. Second, payment percentages can be reduced by trust actuarial reviews. A claim filed and approved at a higher payment percentage will be paid at that rate even if a subsequent reduction takes effect.

For new mesothelioma diagnoses, the practical timeline involves diagnosis confirmation, medical record assembly, exposure history development with an attorney, trust claim filing, trust review and approval, and payment. The full process can take six months to a year or more depending on the trust’s processing volume.

See the mesothelioma legal options guide for the broader framework that integrates trust claims with civil litigation options.

What This Trust Profile Templates

The Celotex trust profile is the first in a series of construction trades trust profiles. The same structural elements apply to other major construction trades trusts: bankruptcy filing date, trust establishment date, covered product line, disease tier structure, payment percentage, and claim filing process. Future profiles will cover the US Gypsum Asbestos PI Trust (drywall joint compound), the Owens Corning Asbestos PI Trust (pipe and equipment insulation), the Armstrong World Industries Asbestos PI Trust (ceiling and flooring), the Babcock and Wilcox Trust (industrial boilers), the WR Grace Trust (vermiculite and chemical products), and others.

Each profile follows the same template. The goal is for people with mesothelioma and their families to be able to identify which trusts apply to a specific exposure history, understand the basic claim filing requirements, and have a clear picture of how the 524(g) trust system operates.

The trusts are public entities operating under court-approved procedures. Their TDPs are publicly available. Their annual reports document their financial position and claim volumes. The information needed to evaluate trust claim eligibility is available; what’s typically missing is the structured presentation of how the trusts work and how to connect a personal exposure history to the trust system.

That’s what these profiles are for.